Some five years into a pneumococcal vaccine patent dispute in South Korea, SK Bioscience has emerged victorious over Pfizer.

Having already worked with clinical trial sites in more than 14 states, CTAC will now take its work nationwide, the ...

The MoU underscores a shared commitment to strengthening Abu Dhabi’s position as a global hub for healthcare innovation ...

SK bioscience wins patent lawsuit against Pfizer over pneumococcal vaccine in Korea: Gyeonggi-do, Republic of Korea Friday, May 23, 2025, 10:00 Hrs [IST] SK bioscience, a global i ...

Dr. Nadine Tarcha, Medical Director at Pfizer Gulf, highlighted the company’s role in shaping the future of healthcare research through meaningful partnerships. “At Pfizer, we believe real-world data ...

Dr. Nadine Tarcha, Medical Director at Pfizer Gulf, highlighted the company’s role in shaping the future of healthcare research through meaningful partnerships. “At Pfizer, we believe real ...

Pfizer (NYSE:PFE) indicated plans to explore acquisitions or partnerships to add cardiometabolic assets, including weight loss therapies, to the pipeline, following a major trial setback this month.

No patent infringement found in exports of individual conjugate bulk substances and research-use finished products of PCV13 ...

Overview of RNA Therapeutics MarketThe Global RNA Therapeutics Market is valued at USD 10.9 Billion in 2024 and is projected ...

Pfizer (NYSE:PFE) is overhauling its cardiometabolic ... antagonist and pursuing external opportunities that could include partnerships or acquisitions. That strategic pivot comes as shares ...